showed a trendp = 0.07
Indeed, in a meta-analysis of almost 29,000 patients with COVID-19, use of RAAS inhibitors for any condition showed a trend to lower risk of death or critical events (odds ratio 0.67, 95% CI 0.43 to 1.03, p = 0.07).
Indeed, in a meta-analysis of almost 29,000 patients with COVID-19, use of RAAS inhibitors for any condition showed a trend to lower risk of death or critical events (odds ratio 0.67, 95% CI 0.43 to 1.03, p = 0.07).